XML 38 R22.htm IDEA: XBRL DOCUMENT v3.2.0.727
Common Stock and Stockholders' Equity (Tables)
3 Months Ended
Jun. 30, 2015
Equity [Abstract]  
Schedule of Stock Option and RSU Award Activities

The following table summarizes the Company’s stock option and RSU award activities for the three months ended June 30, 2015 (in thousands, except per share information):

 

     Options Outstanding      RSUs Outstanding  
                 

Weighted-

Average
Remaining

Contractual

                 

Weighted-

Average

    

Weighted-

Average
Remaining

Contractual

        
     Number    

Weighted-

Average

        Aggregate      Number    

Grant

Date

        Aggregate  
     of
Shares
    Exercise
Price
     Term
(in years)
     Intrinsic
Value
     of
Shares
    Fair
Value
     Term
(in years)
     Intrinsic
Value
 

Outstanding - April 1, 2015

     9,422      $ 10.08         7.9       $ 231,964         723      $ 23.87         3.5       $ 25,098   

Stock options granted

     391        30.78                    

RSU granted

                522        30.93         

Stock options exercised

     (356     4.26            9,883              

Stock options canceled/forfeited

     (137     16.98                    

RSU canceled/forfeited

                (16     25.54         
  

 

 

            

 

 

         

Outstanding - June 30, 2015

     9,320      $ 11.07         7.5       $ 224,810         1,229      $ 26.85         3.6       $ 43,253   
  

 

 

            

 

 

         
Schedule of Cost of Revenue, Research and Development, Sales and Marketing and General and Administrative Expenses

Cost of revenue, research and development, sales and marketing, and general and administrative expenses were as follows (in thousands):

 

     Three Months Ended June 30,  
     2015      2014  

Cost of revenue

   $ 251       $ 93   

Research and development

     1,038         202   

Sales and marketing

     1,976         849   

General and administrative

     1,394         787   
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 4,659       $ 1,931